Chop. chop. chop.
Pfizer cuts away 15 more programs since September when it announced that it will be cutting its R&D spend by $1.5-2 B. Since then, it has been busy cutting the 15 drug programs and closing its main European R&D site in Sandwich, Kent, UK.
Pfizer says it now plans to center its R&D in hubs located in Cambridge, UK and Boston, MA.
Posted by Bruce Lehr March 2nd 2011.